Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies, GeneSeek Settle Patent Dispute

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has reached a settlement and licensing agreement with GeneSeek, resolving a patent dispute between the firms.

Genetic Technologies is granting GeneSeek non-exclusive rights to a number of its patents pertaining to non-coding DNA technology. Other terms were not disclosed.

GeneSeek, a Neogen company that provides agrigenomic and veterinary products and services, was one of 10 firms sued by Genetic Technologies in May 2011 for alleged infringement of US Patent No. 5,612,179, titled "Intron Sequence Analysis Method for Detection of Adjacent Locus Alleles as Haplotypes."

Along with Neogen/GeneSeek, the firms named in the lawsuit were Agilent Technologies; Bristol-Myers Squibb; Eurofins STA Laboratories; GlaxoSmithKline; Hologic; Merial; Navigenics; Pfizer; and 454 Life Sciences.

GeneSeek is the fourth firm to settle with Genetic Technologies, the Australian genetic test development firm said. It previously reached deals with Navigenics, Hologic, and Eurofins. Discussions with other companies named in the lawsuit are ongoing and progressing, Genetic Technologies added.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.